APA (7th ed.) Citation

United States. Office of National Drug Control Policy, United States. Congress. House. Committee on Appropriations, United States. Congress. House. Committee on Oversight and Accountability, United States. Congress. House. Committee on Energy and Commerce, United States. Congress. House. Committee on the Judiciary, United States. Congress. Senate. Committee on Appropriations, . . . United States. Congress. Senate. Committee on the Judiciary. (2024). Fentanyl adulterated or associated with xylazine implementation report. The White House, Executive Office of the President, Office of National Drug Control Policy.

Chicago Style (17th ed.) Citation

United States. Office of National Drug Control Policy, United States. Congress. House. Committee on Appropriations, United States. Congress. House. Committee on Oversight and Accountability, United States. Congress. House. Committee on Energy and Commerce, United States. Congress. House. Committee on the Judiciary, United States. Congress. Senate. Committee on Appropriations, Education United States. Congress. Senate. Committee on Health, and United States. Congress. Senate. Committee on the Judiciary. Fentanyl Adulterated or Associated with Xylazine Implementation Report. Washington, D.C.: The White House, Executive Office of the President, Office of National Drug Control Policy, 2024.

MLA (9th ed.) Citation

United States. Office of National Drug Control Policy, et al. Fentanyl Adulterated or Associated with Xylazine Implementation Report. The White House, Executive Office of the President, Office of National Drug Control Policy, 2024.